Viewing nowFosirinjenjeong 10 mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Withers Pharmaceutical Co., Ltd.

MFDS item code 202201028 · Approved 2022.03.11 · Insurance code 660703740
Improves blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be used as an adjunct to diet and exercise, and can be administered alone or in combination with other medications. It is particularly beneficial for patients whose blood sugar is not adequately controlled, as well as those with cardiovascular disease or risk factors. For detailed information regarding cardiovascular events, please refer to the professional guidance. Thus, this medication is effectively used to improve blood sugar control.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. Patients allergic to the active ingredient or excipients should not take this medication. Additionally, patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Patients with genetic issues such as lactose intolerance or glucose-galactose malabsorption should also avoid this medication. Dialysis patients should not use this medication. Patients with decreased fluid volume or renal impairment should be administered this medication with caution. Since this medication may cause a decrease in blood pressure or sudden changes in kidney function, fluid status and kidney function must be thoroughly assessed before administration. Particular caution is needed for patients with impaired kidney function, the elderly, or those taking diuretics, as they are at a higher risk of hypotension. When taking this medication, it is important to observe for abnormal reactions such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis. Genital infections are particularly common in women, and patients with a history of infection are at higher risk for recurrence. While this medication assists in blood sugar control, its effectiveness may be reduced in patients with severely impaired kidney function. Additionally, when combined with medications such as insulin or sulfonylureas that can cause hypoglycemia, the risk of hypoglycemia may increase, necessitating adjustments in the dosage of these medications. Pregnant or breastfeeding women are advised not to take this medication. If pregnancy is confirmed, this medication should be discontinued immediately, and its use should be avoided during breastfeeding. During the period of taking this medication, it is important to regularly monitor not only blood sugar levels but also fluid status, kidney function, and signs of infection. If unusual symptoms occur, medical consultation should be sought immediately. In case of overdose, there is no specific antidote, so appropriate treatment should be pursued based on symptoms, and hospitalization may be necessary if required. Lastly, the safety and efficacy of this medication in children have not been established, so it should not be used in pediatric patients. Keep this medication out of the reach of children and store it in its original container.
vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, reduced creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebrovascular hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, paresthesia, cerebral ischemia, nerve compression, urinary sepsis, pyelonephritis, hyperglycemia, sensory loss, headache, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a long time.
Yellow, biconvex, diamond-shaped film-coated tablet
28 tablets/box [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Withers Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.